Correspondence on "development and validation of a nomogram to predict the efficacy of PD-1/PD-L1 inhibitors in patients with nasopharyngeal carcinoma"

被引：0
|
作者：
Ragavendran, Chinnasamy [1 ]
机构：
[1] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll & Hosp, Dept Cariol, Chennai 600077, India
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年
关键词：
D O I：
10.1007/s12094-024-03808-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1853 / 1854
页数：2
相关论文
共 50 条
  • [21] PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
    Zhang, Ke
    Kong, Xiangyi
    Li, Yuan
    Wang, Zhongzhao
    Zhang, Lin
    Xuan, Lixue
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [22] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [23] PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
    Li, Qian
    Han, Jingjing
    Yang, Yonglin
    Chen, Yu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors
    Sadal Refae
    Jocelyn Gal
    Nathalie Ebran
    Josiane Otto
    Delphine Borchiellini
    Frederic Peyrade
    Emmanuel Chamorey
    Patrick Brest
    Gérard Milano
    Esma Saada-Bouzid
    Investigational New Drugs, 2020, 38 : 160 - 171
  • [25] Dynamic changes of patelet-to-lymphocyte ratio predict efficacy of PD-1/PD-L1 inhibitors in NSCLC
    Zhou, F.
    Xiong, A.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [26] Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors
    Refae, Sadal
    Gal, Jocelyn
    Ebran, Nathalie
    Otto, Josiane
    Borchiellini, Delphine
    Peyrade, Frederic
    Chamorey, Emmanuel
    Brest, Patrick
    Milano, Gerard
    Saada-Bouzid, Esma
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (01) : 160 - 171
  • [27] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [28] Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors
    Hwang, Inhwan
    Park, Inkeun
    Yoon, Shin-kyo
    Lee, Jae Lyun
    CLINICAL GENITOURINARY CANCER, 2020, 18 (02) : E122 - E133
  • [29] Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
    Ao Zhang
    Guanqing Zhong
    Luocan Wang
    Rongzeng Cai
    Runkun Han
    Caixia Xu
    Shulin Chen
    Peng Sun
    Hao Chen
    Cancer Cell International, 21
  • [30] Efficacy of PD-1 and PD-L1 inhibitors in older adults: A meta-analysis
    Elias, Rawad
    Giobbie-Hurder, Anita
    Rahma, Osama E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345